Document Detail


Different magnetic resonance imaging features in two types of nontraumatic rabbit osteonecrosis models.
MedLine Citation:
PMID:  18701230     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A single injection of high-dose steroid (20 mg/kg) has been reported to induce necrotic lesions in the proximal metaphysis and diaphysis of the rabbit femur. In the rabbit osteonecrosis (ON) model induced by two-dose horse serum injections, contrast-enhanced magnetic resonance imaging (MRI) and T2*-weighted dynamic MRI have been reported to detect necrotic lesions at 3 days after the second serum injection sensitively. The purpose of the present study was to determine whether contrast-enhanced MRI and T2*-weighted dynamic MRI could detect early development of necrotic lesions in the rabbit proximal femora after a single high-dose steroid injection and compare MRI features of the two types of nontraumatic rabbit ON models. We performed nonenhanced MRI, contrast-enhanced MRI and T2*-weighted dynamic MRI of bilateral proximal femora 3 days (10 femora), 1 week (10 femora), 3 weeks (10 femora), 6 weeks (18 femora) and 9 weeks (18 femora) after a single 20 mg/kg steroid injection. Femoral signal intensity of each T2*-weighted dynamic MRI was measured from a 1-cm(2) region of interest in the proximal metaphysis and diaphysis. As a control, MRI was performed in untreated animals (six femora). Histologically, no necrotic lesions were observed in the proximal femora at 3 days and 1 week. Bone marrow necrosis was observed in four (40%) femora at 3 weeks, two (11.1%) femora at 6 weeks and six (33.3%) femora at 9 weeks. Bone marrow lesion completely replaced by granulation tissue was observed in one femur at 6 weeks and one femur at 9 weeks. Histologic evidence of repair tissue surrounding bone marrow necrosis was seen after 6 weeks. Average lesion area including repair tissue was 4.40 mm(2) (range, 0.32 to 20.2 mm(2)). At 9 weeks, contrast-enhanced MRI could detect four (66.7%) femora with bone marrow necrosis of more than 4 mm(2) in the lesion area, while T2*-weighted dynamic images showed a finding of complete ischemia in only one of these four femora. In conclusion, neither contrast-enhanced MRI nor T2*-weighted dynamic MRI could detect early development of necrotic lesions in the single-dose steroid ON model. These results indicated that development of necrotic lesions in the single-dose steroid ON model was not accompanied by as diffuse a femoral hemodynamic change as the two-dose horse serum ON model.
Authors:
Masaki Takao; Nobuhiko Sugano; Takashi Nishii; Takashi Sakai; Nobuo Nakamura; Hideki Yoshikawa
Publication Detail:
Type:  Journal Article     Date:  2008-08-12
Journal Detail:
Title:  Magnetic resonance imaging     Volume:  27     ISSN:  0730-725X     ISO Abbreviation:  Magn Reson Imaging     Publication Date:  2009 Feb 
Date Detail:
Created Date:  2009-02-09     Completed Date:  2009-04-16     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8214883     Medline TA:  Magn Reson Imaging     Country:  United States    
Other Details:
Languages:  eng     Pagination:  233-9     Citation Subset:  IM    
Affiliation:
Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan. masaki_tko@umin.ac.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Bone Marrow / pathology
Contrast Media / administration & dosage
Disease Models, Animal*
Femur / pathology*
Gadolinium DTPA / administration & dosage
Horses / blood
Image Processing, Computer-Assisted
Magnetic Resonance Imaging / methods*
Male
Methylprednisolone
Osteonecrosis / chemically induced,  pathology*
Rabbits
Statistics, Nonparametric
Chemical
Reg. No./Substance:
0/Contrast Media; 80529-93-7/Gadolinium DTPA; 83-43-2/Methylprednisolone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Imaging water fluxes in porous media by magnetic resonance imaging using D(2)O as a tracer.
Next Document:  Oral and i.v. pharmacokinetics of isosteviol in rats as assessed by a new sensitive LC-MS/MS method.